가축 진단 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 대상 동물별, 검사 카테고리별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

Livestock Diagnostics Market Summary

The global livestock diagnostics market size was estimated at USD 3.4 billion in 2025 and is projected to reach USD 8.1 billion by 2033, growing at a CAGR of 11.5% from 2026 to 2033. The market is witnessing significant growth driven by the rising global demand for animal-derived food products, which increases the need for effective disease monitoring to maintain productivity and supply stability.

The growing prevalence of infectious, zoonotic, and foodborne diseases in livestock further accelerates adoption as early detection helps reduce economic losses and prevent outbreaks.

Moreover, the increasing adoption of digital surveillance platforms and data-driven tools is strengthening demand for advanced livestock diagnostics solutions as stakeholders' focus on early disease detection and faster response mechanisms. For instance, according to an article published by the Regents of the University of California, Davis campus, in October 2025, the University of California, Davis School of Veterinary Medicine, launched the upgraded Disease BioPortal, which supports veterinarians, producers, and diagnostic laboratories in monitoring livestock health trends through integrated data and predictive analytics. The platform consolidates diagnostic and field data from multiple sources and provides interactive dashboards and real-time insights to improve outbreak detection and farm management decisions.

The adoption of this platform by major swine producers, pharmaceutical companies, and veterinary clinics reflects growing industry reliance on connected diagnostic ecosystems to manage disease risks. By enabling faster identification of health issues and improving biosecurity planning, such digital systems increase the utilization of laboratory testing, surveillance diagnostics, and field-based screening tools. As more livestock sectors integrate similar monitoring solutions, the demand for diagnostic tests, data integration services, and laboratory infrastructure is expected to rise, thereby contributing to the overall growth of the livestock diagnostics industry.

In addition, rising outbreaks of animal diseases significantly increase the demand for rapid and accurate disease detection tools in the livestock sector. For instance, according to an article published by PoultryMed, in February 2026, Argentina's National Health and Agrifood Quality Service (SENASA) confirmed the presence of a Highly Pathogenic Avian Influenza (H5 subtype) outbreak in a commercial poultry farm, along with virus detection in wild bird populations, leading to strengthened surveillance and stricter control measures across farms and nearby areas.

The culling of infected flocks and the voluntary suspension of poultry exports highlight the economic impact of such events, prompting producers, exporters, and regulators to strengthen routine testing, environmental monitoring, and biosecurity screening. As authorities and industry players aim to prevent further spread and safeguard trade, the need for laboratory-based diagnostics, field testing kits, and continuous monitoring systems increases, thereby supporting the market growth.

Global Livestock Diagnostics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global livestock diagnostics market report based on product, testing category, animal, end use, and region.

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Consumables, Reagents & Kits
• Equipment & Instruments
• Animal Outlook (Revenue, USD Million, 2021 - 2033)
• Cattle
• Poultry
• Swine
• Other Livestock Animals
• Testing Category Outlook (Revenue, USD Million, 2021 - 2033)
• Clinical Chemistry
• Microbiology
• Parasitology
• Histopathology
• Cytopathology
• Hematology
• Immunology & Serology
• Imaging
• Molecular Diagnostics
• Other Categories
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Reference Laboratories
• Veterinarians
• Animal Owners/ Producers
• Region Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • UAE
  • Saudi Arabia
  • Kuwait
  • Qatar
  • Oman

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Testing Category
  • 1.2.3. Animal
  • 1.2.4. End Use
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information/Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Model 1: Commodity Flow Analysis
  • 1.7.2. Model 2: Bottom Up Analysis
  • 1.7.3. Model 3: Multivariate Analysis
• 1.8. List of Secondary Sources
• 1.9. List of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Market Variable Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary/Related Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing Prevalence of Diseases in Livestock
    • 3.2.1.2. Growing Demand for Animal Derived Products
    • 3.2.1.3. Supportive Initiatives, By Government.
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Lack of Standardized Regulations
    • 3.2.2.2. Lack of Awareness
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
• 3.3. Technology Landscape
• 3.4. Pricing Analysis
• 3.5. Estimated Animal Population, By Key Species, Key Countries, 2025
• 3.6. Disease Prevalence Analysis, 2025
• 3.7. Market Analysis Tools
  • 3.7.1. Porter's Five Forces Analysis
  • 3.7.2. PESTEL by SWOT Analysis

Chapter 4. Livestock Diagnostics Market: Product Estimates & Trend Analysis

• 4.1. Livestock Diagnostics Market, By Product: Segment Dashboard
• 4.2. Livestock Diagnostics Market, By Product Movement Analysis
• 4.3. Livestock Diagnostics Market Estimates & Forecasts, by Product, 2021 to 2033 (USD Million)
• 4.4. Consumables, Reagents & Kits
  • 4.4.1. Consumables, Reagents & Kits Market Estimates and Forecasts, 2021 - 2033(USD Million)
• 4.5. Equipment & Instruments
  • 4.5.1. Equipment & Instruments Market Estimates and Forecasts, 2021 - 2033(USD Million)

Chapter 5. Livestock Diagnostics Market: By Testing Category Estimates & Trend Analysis

• 5.1. Livestock Diagnostics Market, By Testing Category: Segment Dashboard
• 5.2. Livestock Diagnostics Market, By Testing Category Movement Analysis
• 5.3. Livestock Diagnostics Market Estimates & Forecasts, by Testing Category, 2021 to 2033 (USD Million)
• 5.4. Clinical Chemistry
  • 5.4.1. Clinical Chemistry Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Microbiology
  • 5.5.1. Microbiology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Parasitology
  • 5.6.1. Parasitology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Histopathology
  • 5.7.1. Histopathology Market Estimates and Forecasts, 2021 - 2033(USD Million)
• 5.8. Cytopathology
  • 5.8.1. Cytopathology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.9. Hematology
  • 5.9.1. Hematology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.10. Immunology & Serology
  • 5.10.1. Immunology & Serology Market Estimates and Forecasts, 2021 - 2033(USD Million)
• 5.11. Imaging
  • 5.11.1. Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.12. Molecular Diagnostics
  • 5.12.1. Molecular Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.13. Other Categories
  • 5.13.1. Other Categories Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Livestock Diagnostics Market: By Animal Type Estimates & Trend Analysis

• 6.1. Livestock Diagnostics Market, By Animal: Segment Dashboard
• 6.2. Livestock Diagnostics Market, By Animal Movement Analysis
• 6.3. Livestock Diagnostics Market Estimates & Forecasts, by Animal, 2021 to 2033 (USD Million)
• 6.4. Cattle
  • 6.4.1. Cattle Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Poultry
  • 6.5.1. Large Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Swine
  • 6.6.1. Swine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Other Livestock Animals
  • 6.7.1. Other Livestock Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Livestock Diagnostics Market: By End Use Estimates & Trend Analysis

• 7.1. Livestock Diagnostics Market, By End Use: Segment Dashboard
• 7.2. Livestock Diagnostics Market, By End Use Movement Analysis
• 7.3. Livestock Diagnostics Market Estimates & Forecasts, by End Use, 2021 to 2033 (USD Million)
• 7.4. Reference Laboratories
  • 7.4.1. Reference Laboratories Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Veterinarians
  • 7.5.1. Veterinarians Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Animal Owners/Producers
  • 7.6.1. Veterinarians Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Livestock Diagnostics Market: By Regional Estimates & Trend Analysis

• 8.1. Region Market Dashboard
• 8.2. Region Market Share Analysis, 2025 & 2033
• 8.3. North America
  • 8.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.2. U.S
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Competitive Scenario
    • 8.3.2.3. Regulatory Framework
    • 8.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Competitive Scenario
    • 8.3.3.3. Regulatory Framework
    • 8.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.4. Mexico
    • 8.3.4.1. Key Country Dynamics
    • 8.3.4.2. Competitive Scenario
    • 8.3.4.3. Regulatory Framework
    • 8.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.2. UK
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.3. Germany
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Competitive Scenario
    • 8.4.5.3. Regulatory Framework
    • 8.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Competitive Scenario
    • 8.4.6.3. Regulatory Framework
    • 8.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.7. Denmark
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Competitive Scenario
    • 8.4.7.3. Regulatory Framework
    • 8.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.8. Sweden
    • 8.4.8.1. Key Country Dynamics
    • 8.4.8.2. Competitive Scenario
    • 8.4.8.3. Regulatory Framework
    • 8.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.9. Norway
    • 8.4.9.1. Key Country Dynamics
    • 8.4.9.2. Competitive Scenario
    • 8.4.9.3. Regulatory Framework
    • 8.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.2. Japan
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.3. China
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.5. Australia
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.6. Thailand
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Framework
    • 8.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.7. South Korea
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.7. MEA
  • 8.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.3. UAE
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.4. Saudi Arabia
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory Framework
    • 8.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Competitive Scenario
    • 8.7.5.3. Regulatory Framework
    • 8.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.6. Qatar
    • 8.7.6.1. Key Country Dynamics
    • 8.7.6.2. Competitive Scenario
    • 8.7.6.3. Regulatory Framework
    • 8.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.7. Oman
    • 8.7.7.1. Key Country Dynamics
    • 8.7.7.2. Competitive Scenario
    • 8.7.7.3. Regulatory Framework
    • 8.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
  • 9.1.1. Market Leaders
  • 9.1.2. Emerging Players
• 9.2. Market Share/Assessment Analysis, 2025 (Heat Map Analysis)
• 9.3. Company Profiles
  • 9.3.1. IDEXX Laboratories, Inc.
    • 9.3.1.1. Participant's Overview
    • 9.3.1.2. Financial Performance
    • 9.3.1.3. Product Benchmarking
    • 9.3.1.4. Strategic Initiatives
  • 9.3.2. Zoetis
    • 9.3.2.1. Participant's Overview
    • 9.3.2.2. Financial Performance
    • 9.3.2.3. Product Benchmarking
    • 9.3.2.4. Strategic Initiatives
  • 9.3.3. Antech Diagnostics, Inc. (Mars Inc.).
    • 9.3.3.1. Participant's Overview
    • 9.3.3.2. Financial Performance
    • 9.3.3.3. Product Benchmarking
    • 9.3.3.4. Strategic Initiatives
  • 9.3.4. Agrolabo S.p.A.
    • 9.3.4.1. Participant's Overview
    • 9.3.4.2. Financial Performance
    • 9.3.4.3. Product Benchmarking
    • 9.3.4.4. Strategic Initiatives
  • 9.3.5. Embark Veterinary, Inc.
    • 9.3.5.1. Participant's Overview
    • 9.3.5.2. Financial Performance
    • 9.3.5.3. Product Benchmarking
    • 9.3.5.4. Strategic Initiatives
  • 9.3.6. Esaote SPA
    • 9.3.6.1. Participant's Overview
    • 9.3.6.2. Financial Performance
    • 9.3.6.3. Product Benchmarking
    • 9.3.6.4. Strategic Initiatives
  • 9.3.7. Thermo Fisher Scientific, Inc.
    • 9.3.7.1. Participant's Overview
    • 9.3.7.2. Financial Performance
    • 9.3.7.3. Product Benchmarking
    • 9.3.7.4. Strategic Initiatives
  • 9.3.8. Innovative Diagnostics SAS
    • 9.3.8.1. Participant's Overview
    • 9.3.8.2. Financial Performance
    • 9.3.8.3. Product Benchmarking
    • 9.3.8.4. Strategic Initiatives
  • 9.3.9. Virbac
    • 9.3.9.1. Participant's Overview
    • 9.3.9.2. Financial Performance
    • 9.3.9.3. Product Benchmarking
    • 9.3.9.4. Strategic Initiatives
  • 9.3.10. FUJIFILM Corporation
    • 9.3.10.1. Participant's Overview
    • 9.3.10.2. Financial Performance
    • 9.3.10.3. Product Benchmarking
    • 9.3.10.4. Strategic Initiatives